Skip to main content
. 2023 Jan 24;9(2):e13170. doi: 10.1016/j.heliyon.2023.e13170

Table 2.

Patient characteristics according to their p16INK4A expression in IHC analysis.

Total (n = 21) p16INK4A-negative (n = 7) p16INK4A-positive (n = 14) p value
Age, median 66.00 70.00 61.00 0.062a
Male, n (%) 12 (57.14) 5 (71.43) 7 (50.00) 0.64b
T staging, n (%) 0.13b
 1 0 (0) 0 (0) 0 (0)
 2 1 (4.76) 0 (0) 1 (7.14)
 3 19 (90.48) 6 (85.71) 13 (92.86)
 4 1 (4.76) 1 (14.29) 0 (0)
N staging, n (%) 0.85b
 0 8 (38.10) 3 (42.86) 5 (35.71)
 1 6 (28.57) 1 (14.29) 5 (35.71)
 2 7 (33.33) 3 (42.86) 4 (28.57)
M staging, n (%) 1.00b
 0 21 (100) 7 (100) 14 (100)
 1 0 (0) 0 (0) 0 (0)
Localization, n (%) 0.15b
 Ascending 0 (0) 0 (0) 0 (0)
 Transverse 1 (4.76) 1 (14.29) 0 (0)
 Descending/sigmoid/rectum 20 (95.24) 6 (85.71) 14 (100)
Microsatellite stable, n (%) 21 (100) 7 (100) 14 (100) 1.00b
a

p values were obtained from Mann-Whitney U test.

b

p values were obtained from Chi-square test.